Original Source(s)
Related Content
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min
Same-Day COVID, Flu Vaccination Appears Safe
Study found no increased 90-day risk of serious adverse events with coadministration compared with vaccination alone.
July 8, 2026
-
2 min
More Physicians Enter Politics
Viewpoint explores how more physician-candidates could reshape both public service and public trust in medicine.
by Kerri Miller
July 7, 2026
-
4 min